Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury

Successful cell therapy requires cells to resist the hostile ischemic myocardium, be retained to continue secreting cardioprotective growth factors/exosomes, and resist immunological host responses. Clinically relevant stem/progenitor cells in a rodent model of acute myocardial infarction (MI) demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunasekaran, Muthukumar, Mishra, Rachana, Saha, Progyaparamita, Morales, David, Cheng, Wen-Chih, Jayaraman, Arun R., Hoffman, Jessica R., Davidson, Lauran, Chen, Ling, Shah, Aakash M., Bittle, Gregory, Fu, Xuebin, Tulshyan, Antariksh, Abdullah, Mohamed, Kingsbury, Tami, Civin, Curt, Yang, Peixin, Davis, Michael E., Bolli, Roberto, Hare, Joshua M., Sharma, Sudhish, Kaushal, Sunjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283895/
https://www.ncbi.nlm.nih.gov/pubmed/35847554
http://dx.doi.org/10.1016/j.isci.2022.104656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283895/
https://www.ncbi.nlm.nih.gov/pubmed/35847554
http://dx.doi.org/10.1016/j.isci.2022.104656

Ejemplares similares